查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1556865

組織心臟瓣膜的全球市場

Tissue Heart Valves
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 174 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球組織心臟瓣膜市場預計將達到 18 億美元

全球組織心臟瓣膜市場預計 2023 年為 15 億美元，預計到 2030 年將達到 18 億美元，2023-2030 年分析期間複合年成長率為 2.4%。支架瓣膜是本報告分析的細分市場之一，預計複合年成長率為 2.6%，到分析期結束時將達到 13 億美元。在分析期間，無支架瓣膜細分市場的複合年成長率預計為 1.9%。

美國市場預估為4.097億美元，中國預期複合年成長率為4.9%

預計 2023 年美國組織心臟瓣膜市場規模將達 4.097 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達3.54億美元，2023-2030年分析期間複合年成長率為4.9%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 0.6% 和 1.8%。在歐洲，德國的複合年成長率預計為 1.2%。

全球組織心臟瓣膜市場－主要趨勢與促進因素總結

組織心臟瓣膜如何改善心血管手術的結果？

組織心臟瓣膜，也稱為生物瓣膜，透過提供機械瓣膜的替代品，具有更自然的血流動力學並減少抗凝血治療的需求，正在徹底改變心血管手術。這些瓣膜通常由動物組織製成，例如豬心瓣膜或牛心包膜，並經過處理以防止排斥並確保耐用性。組織瓣膜對於某些患者族群特別有利，包括老年人，他們無法忍受機械瓣膜所需的終身抗凝血治療。使用組織瓣膜可以透過提供更安靜的操作和不太嚴格的血液稀釋治療來顯著改善生活品質。此外，這些瓣膜的設計和製造方面的進步提高了它們的耐用性和性能，使其適用於更廣泛的患者，並因其生理益處和易於植入而越來越受到外科醫生的青睞。

哪些技術創新正在增強組織心臟瓣膜的功能？

組織心臟瓣膜的創新著重於提高耐用性、降低併發症風險和提高患者適用性。一項重要的進展是使用新的抗鈣化治療，透過防止鈣沉積（生物瓣膜退化的常見原因）來延長組織瓣膜的壽命。此外，透過採用電腦輔助設計和製造等技術，我們製造的瓣膜更接近患者心臟的自然解剖結構，改善貼合性和功能，並減少瓣膜洩漏和瓣膜洩漏故障的風險。也開發了將組織元件和合成材料結合的混合瓣膜，以提供機械瓣膜的耐用性，同時保持組織瓣膜的生理益處。這些技術進步不僅擴大了組織心臟瓣膜對各種患者群體的適用性，而且還提高了心臟瓣膜置換手術的整體安全性和結果。

組織心臟瓣膜如何影響患者的復健和長期健康？

組織心臟瓣膜透過提供更自然的心臟功能並消除終生強化抗凝血治療的需要，對患者的復健和長期健康產生重大影響。與組織瓣膜瓣膜的患者形成血栓的風險較低，通常生活方式和飲食限制較少。抗凝血劑需求的減少降低了出血併發症的風險，這對於老年人和生活方式因素增加出血風險的患者尤其重要。從長遠來看，與組織瓣膜相關的更多生理流體動態也往往會導致更好的心臟功能，有助於改善整體健康和福祉。然而，儘管組織瓣膜的使用壽命不如機械瓣膜，但瓣膜治療和技術的進步不斷延長其使用壽命，使其成為越來越多患者的可行選擇。

推動組織心臟瓣膜市場成長的趨勢是什麼？

全球老化、心臟瓣膜疾病發生率增加以及對微創手術干預的偏好等趨勢推動了組織心臟瓣膜市場的成長。隨著人口老化，需要瓣膜置換的疾病（例如主動脈瓣狹窄）的盛行率不斷增加。組織瓣膜在老年手術中特別有吸引力，因為它們符合患者的自然生理機能並減少抗凝血治療的需要。此外，使用組織瓣膜的經導管主動脈瓣置換術（TAVR）等微創手術的需求不斷成長，正在顯著影響市場的成長。這些手術可以加速患者的康復，通常適合那些被認為是進行心臟直視手術的高風險患者。最後，生物瓣膜技術的不斷改進，透過延長使用壽命和改善患者治療效果來增加其吸引力，也是推動組織心臟瓣膜市場擴張的關鍵因素。

受訪企業範例（36家知名企業）

  • Abbott Cardiovascular
  • Arrotek Medical
  • Artivion, Inc
  • Beijing Balance Medical Technology Co.,Ltd.
  • Boston Scientific Corporation
  • Braile Biomedica
  • BridgeMed Solutions
  • Colibri Heart Valve LLC
  • Edwards Lifesciences Corporation
  • JC Medical, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP24235

Global Tissue Heart Valves Market to Reach US$1.8 Billion by 2030

The global market for Tissue Heart Valves estimated at US$1.5 Billion in the year 2023, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 2.4% over the analysis period 2023-2030. Stented Valves, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Stentless Valves segment is estimated at 1.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$409.7 Million While China is Forecast to Grow at 4.9% CAGR

The Tissue Heart Valves market in the U.S. is estimated at US$409.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$354.0 Million by the year 2030 trailing a CAGR of 4.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.6% and 1.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Global Tissue Heart Valves Market - Key Trends and Drivers Summarized

How Are Tissue Heart Valves Enhancing Cardiac Surgery Outcomes?

Tissue heart valves, also known as bioprosthetic valves, are revolutionizing cardiac surgery by providing alternatives to mechanical valves with more natural hemodynamics and reduced requirements for anticoagulation therapy. These valves are typically made from animal tissues, such as porcine heart valves or bovine pericardium, which are treated to prevent rejection and ensure durability. Tissue valves are particularly advantageous for certain patient groups, including older adults, who may not tolerate the lifelong anticoagulation medication required with mechanical valves. The use of tissue valves can significantly improve quality of life by offering quieter operation and less rigid blood thinning regimes. Moreover, advancements in the design and fabrication of these valves have improved their durability and performance, making them suitable for a wider range of patients and increasingly preferred by surgeons for their physiological benefits and ease of implantation.

What Innovations Are Enhancing the Functionality of Tissue Heart Valves?

Innovations in tissue heart valves are focusing on extending durability, reducing the risk of complications, and enhancing patient compatibility. One significant advancement is the use of novel anticalcification treatments that extend the lifespan of tissue valves by preventing calcium deposits, a common cause of degeneration in bioprosthetic valves. Additionally, technologies such as computer-aided design and manufacturing are being employed to create valves that more closely mimic the natural anatomy of the patient’s heart, improving fit and function while reducing the risk of leakage or valve failure. Hybrid valves that combine tissue elements with synthetic materials are also being developed to offer the durability of mechanical valves while maintaining the physiological advantages of tissue valves. These technological advancements are not only expanding the applicability of tissue heart valves across different patient demographics but also improving the overall safety and outcomes of heart valve replacement surgeries.

How Do Tissue Heart Valves Impact Patient Recovery and Long-Term Health?

Tissue heart valves significantly impact patient recovery and long-term health by providing a more natural heart function and eliminating the need for intense lifelong anticoagulation therapy. Patients with tissue valves typically experience fewer restrictions on their lifestyle and diet compared to those with mechanical valves, as the risk of blood clot formation is lower. This reduction in the need for anticoagulation drugs decreases the risk of bleeding complications, which is particularly important for the elderly or those with lifestyle factors that increase bleeding risks. The more physiological flow dynamics associated with tissue valves also tend to result in better cardiac function over time, contributing to improved overall health and well-being. However, while tissue valves do not last as long as mechanical valves, the advances in valve treatment and technology continue to extend their lifespan, making them a viable option for an increasing number of patients.

What Trends Are Driving Growth in the Tissue Heart Valves Market?

The growth of the tissue heart valves market is driven by trends such as the aging global population, increasing incidences of heart valve diseases, and preferences for less invasive surgical interventions. As the population ages, the prevalence of conditions that require valve replacement, such as aortic stenosis, is rising. Tissue valves are particularly appealing in geriatric surgery due to their compatibility with the patient's natural physiology and reduced requirement for anticoagulation. Additionally, the increasing demand for minimally invasive procedures, such as transcatheter aortic valve replacement (TAVR), which uses tissue valves, is significantly influencing market growth. These procedures allow for quicker patient recovery and are often suitable for patients who are considered high-risk for open-heart surgery. Lastly, continuous improvements in bioprosthetic valve technologies, which enhance their appeal through longer service lives and better patient outcomes, are also key factors driving the expansion of the tissue heart valves market.

Select Competitors (Total 36 Featured) -

  • Abbott Cardiovascular
  • Arrotek Medical
  • Artivion, Inc
  • Beijing Balance Medical Technology Co.,Ltd.
  • Boston Scientific Corporation
  • Braile Biomedica
  • BridgeMed Solutions
  • Colibri Heart Valve LLC
  • Edwards Lifesciences Corporation
  • JC Medical, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tissue Heart Valves - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Preference for Bioprosthetic Over Mechanical Valves Drives Market Growth
    • Rising Global Incidence of Valve Diseases Bolsters Demand for Tissue Heart Valves
    • Minimally Invasive Valve Replacement Techniques Propel Use of Tissue Valves
    • Aging Population Demographics Increase Prevalence of Valve Replacement Surgeries
    • Patient-Specific Customization and 3D Printing Innovations in Valve Manufacturing
    • Global Expansion of Healthcare Infrastructure Improves Access to Valve Replacement Therapy
    • Insurance and Reimbursement Policies Impact Patient Access to Tissue Heart Valves
    • Advancements in Imaging and Diagnostic Techniques Improve Valve Disease Detection
    • Ongoing Research into Anticalcification Treatments to Extend Valve Life
    • Competition from Non-biological Valve Innovations Shapes Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Tissue Heart Valves Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Tissue Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Stented Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Stented Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Stented Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Stentless Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Stentless Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Stentless Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: USA 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • JAPAN
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • CHINA
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: China 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • EUROPE
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Tissue Heart Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • FRANCE
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: France 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • GERMANY
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: UK 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Spain 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Russia 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Tissue Heart Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Australia 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • INDIA
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: India 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: South Korea 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Tissue Heart Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Latin America 16-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Argentina 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Mexico 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Latin America 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Tissue Heart Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Middle East 16-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Iran 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Israel 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Saudi Arabia 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: UAE 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Middle East 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030
  • AFRICA
    • Tissue Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for Tissue Heart Valves by Valve Type - Stented Valves and Stentless Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Africa 16-Year Perspective for Tissue Heart Valves by Valve Type - Percentage Breakdown of Value Sales for Stented Valves and Stentless Valves for the Years 2014, 2024 & 2030

IV. COMPETITION